Macrophages enhance antitumorigenic activity through phagocytosis, but phagocytosis-enhancing therapeutics have not improved acute myeloid leukemia (AML) outcomes. To identify phagocytosis regulators, we performed a CRISPR knockout screen in human AML cells…
Trending
- Between price gouging and diarrhea-causing parasites, lettuce is making trouble at some restaurants
- Antihistamines banned for eczema
- What Britain’s air-con controversy tells us about fighting climate change
- Resume of Lindsay Clancy’s ex-husband testifying about the day he murdered her three children
- Hospice’s poor reputation amid fraud crisis will harm patients, industry experts warn
- Can trees fall due to heat wave?
- More than half of England officially hit by drought – Environment Agency
- Uninsured but fearless, one surgical patient searched the world for a deal
Sialylated CD43 forms a glyco-immune barrier that regulates antileukemic immunity. Science
By 
Add A Comment